These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22614622)

  • 1. Acute coronary syndromes: Early metabolic modulation--a solution for MI?
    van der Horst IC
    Nat Rev Cardiol; 2012 May; 9(7):377-8. PubMed ID: 22614622
    [No Abstract]   [Full Text] [Related]  

  • 2. Glucose-insulin-potassium therapy in patients with acute coronary syndrome: a meta-analysis of randomized controlled trials.
    Jin PY; Zhang HS; Guo XY; Liang WF; Han QF
    BMC Cardiovasc Disord; 2014 Nov; 14():169. PubMed ID: 25425404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of blood glucose in patients with acute coronary syndromes.
    Lipska KJ; Kosiborod M
    Rev Cardiovasc Med; 2012; 13(2-3):e77-88. PubMed ID: 23160165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New evidence of uselessness of intravenous glucose-insulin-potassium infusion in patients with ST-segment elevation myocardial infarction: results of meta-analysis of CREATE-ECLA and OASIS-6 trials].
    Kardiologiia; 2008; 48(1):76. PubMed ID: 18261001
    [No Abstract]   [Full Text] [Related]  

  • 5. Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial.
    Selker HP; Beshansky JR; Sheehan PR; Massaro JM; Griffith JL; D'Agostino RB; Ruthazer R; Atkins JM; Sayah AJ; Levy MK; Richards ME; Aufderheide TP; Braude DA; Pirrallo RG; Doyle DD; Frascone RJ; Kosiak DJ; Leaming JM; Van Gelder CM; Walter GP; Wayne MA; Woolard RH; Opie LH; Rackley CE; Apstein CS; Udelson JE
    JAMA; 2012 May; 307(18):1925-33. PubMed ID: 22452807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory effects of insulin and pro-inflammatory effects of glucose: relevance to the management of acute myocardial infarction and other acute coronary syndromes.
    Dandona P; Chaudhuri A; Ghanim H; Mohanty P
    Rev Cardiovasc Med; 2006; 7 Suppl 2():S25-34. PubMed ID: 17224874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-year outcomes of out-of-hospital administration of intravenous glucose, insulin, and potassium (GIK) in patients with suspected acute coronary syndromes (from the IMMEDIATE [Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care] Trial).
    Selker HP; Udelson JE; Massaro JM; Ruthazer R; D'Agostino RB; Griffith JL; Sheehan PR; Desvigne-Nickens P; Rosenberg Y; Tian X; Vickery EM; Atkins JM; Aufderheide TP; Sayah AJ; Pirrallo RG; Levy MK; Richards ME; Braude DA; Doyle DD; Frascone RJ; Kosiak DJ; Leaming JM; Van Gelder CM; Walter GP; Wayne MA; Woolard RH; Beshansky JR
    Am J Cardiol; 2014 May; 113(10):1599-605. PubMed ID: 24792735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study design for the Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care (IMMEDIATE) Trial: A double-blind randomized controlled trial of intravenous glucose, insulin, and potassium for acute coronary syndromes in emergency medical services.
    Selker HP; Beshansky JR; Griffith JL; D'Agostino RB; Massaro JM; Udelson JE; Rashba EJ; Ruthazer R; Sheehan PR; Desvigne-Nickens P; Rosenberg YD; Atkins JM; Sayah AJ; Aufderheide TP; Rackley CE; Opie LH; Lambrew CT; Cobb LA; Macleod BA; Ingwall JS; Zalenski RJ; Apstein CS
    Am Heart J; 2012 Mar; 163(3):315-22. PubMed ID: 22424000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview of glycemic control in the coronary care unit with recommendations for clinical management.
    Kosiborod M; Deedwania P
    J Diabetes Sci Technol; 2009 Nov; 3(6):1342-51. PubMed ID: 20144388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Very early administration of glucose-insulin-potassium by emergency medical service for acute coronary syndromes: Biological mechanisms for benefit in the IMMEDIATE Trial.
    Selker HP; Harris WS; Rackley CE; Marsh JB; Ruthazer R; Beshansky JR; Rashba EJ; Peter I; Opie LH
    Am Heart J; 2016 Aug; 178():168-75. PubMed ID: 27502865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The insulin cardioplegia trial.
    Lazar HL
    J Thorac Cardiovasc Surg; 2002 May; 123(5):842-4. PubMed ID: 12019367
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardioprotective Effects of Glucose-Insulin-Potassium Infusion in Patients Undergoing Cardiac Surgery: A Systematic Review and Meta-Analysis.
    Hagerman A; Schorer R; Putzu A; Keli-Barcelos G; Licker M
    Semin Thorac Cardiovasc Surg; 2024 Summer; 36(2):167-181. PubMed ID: 36356908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-Reactive protein reactions to glucose-insulin-potassium infusion and relations to infarct size in patients with acute coronary syndromes.
    Alkofide H; Huggins GS; Beshansky JR; Ruthazer R; Peter I; Ray M; Mukherjee JT; Selker HP
    BMC Cardiovasc Disord; 2015 Dec; 15():163. PubMed ID: 26631004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial Protection by Glucose-Insulin-Potassium in Moderate- to High-Risk Patients Undergoing Elective On-Pump Cardiac Surgery: A Randomized Controlled Trial.
    Ellenberger C; Sologashvili T; Kreienbühl L; Cikirikcioglu M; Diaper J; Licker M
    Anesth Analg; 2018 Apr; 126(4):1133-1141. PubMed ID: 29324494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive management of hyperglycaemia in acute coronary syndromes. Study design and rationale of the BIOMArCS 2 glucose trial.
    de Mulder M; Umans VA; Stam F; Cornel JH; Oemrawsingh RM; Boersma E
    Diabet Med; 2011 Oct; 28(10):1168-75. PubMed ID: 21480974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of insulin-glucose infusion on mortality following acute myocardial infarction in patients with diabetes: the diabetes and insulin-glucose infusion in acute myocardial infarction studies.
    Malmberg K; Rydén L
    Semin Thorac Cardiovasc Surg; 2006; 18(4):326-9. PubMed ID: 17395029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperkalemic cardiac arrest after cardiac surgery following high-dose glucose-insulin-potassium infusion for inotropic support.
    Böhrer H; Fleischer F; Krier C
    Anesthesiology; 1988 Dec; 69(6):949-53. PubMed ID: 3057941
    [No Abstract]   [Full Text] [Related]  

  • 18. Glucose-insulin-potassium therapy in patients with STEMI.
    Chaudhuri A; Nesto R; Dandona P
    JAMA; 2008 May; 299(20):2386-7; author reply 2387-8. PubMed ID: 18505943
    [No Abstract]   [Full Text] [Related]  

  • 19. Glucose-insulin-potassium therapy in patients with STEMI.
    Arora RR; Katragadda S
    JAMA; 2008 May; 299(20):2386; author reply 2387-8. PubMed ID: 18505944
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of glucose-insulin-potassium solution added to reperfusion treatment in acute myocardial infarction.
    Türel B; Gemici K; Baran I; Yeşilbursa D; Güllülü S; Aydinlar A; Serdar A; Kazazoğlu AR; Kumbay E; Cordan J
    Anadolu Kardiyol Derg; 2005 Jun; 5(2):90-4. PubMed ID: 15939681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.